Navigation Links
Enigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government
Date:9/18/2008

PORTON DOWN, England, September 18 /PRNewswire/ -- Enigma Diagnostics, the decentralised and point-of-care molecular diagnostics Company, announces that it has been awarded a grant of GBP1.8M from the UK Government's Technology Strategy Board under the "Technologies for Health" programme.

The objective of the programme is to develop a "gold-standard" portable, rapid, automated DNA analysis (PRADA) molecular test system for the diagnosis of infectious diseases in decentralised and point-of-care settings such as GP surgeries. The focus of the programme will be on sexually transmitted diseases including Chlamydia and healthcare associated infections including MRSA.

The PRADA system development will be led by Enigma Diagnostics and based upon its proprietary technology. Researchers at the Centre for Healthcare Associated Infections at Nottingham University and Nottingham Trent University, will develop and validate real-time molecular assays for the platform.

Point-of-care molecular tests for critical infectious diseases are a significant unmet clinical need. Chlamydia is the most common sexually transmitted infection in the developed world. Most people with Chlamydia have no symptoms and many are unaware that they have the infection. If left untreated, Chlamydia can lead to long term health problems, such as infertility and pelvic inflammatory disease. Rapid systems for point-of-care testing will enable healthcare professionals to accurately diagnose Chlamydia and treat it immediately, removing the need to track down patients days or weeks later.

MRSA is a significant public health problem and rapid point-of-care testing is essential for effective patient management. The NHS is introducing MRSA screening for patients admitted to hospitals in order to help reduce severe infections. The new PRADA system will allow rapid testing for emergency and out of hour's admissions, allowing doctors to make quick decisions about how their patients a
'/>"/>

SOURCE Enigma Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Enigma Signs Real-Time PCR Licences With Applera
2. Enigma Diagnostics to Develop Clinical Diagnostics Platform for UK National Chlamydia Screening Programme
3. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
4. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
5. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
6. Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab: Sophora Diagnostic Lab, Inc.
7. Pathwork Diagnostics Closes $20M Financing
8. Exosome Diagnostics Announces Additions to Management Team
9. VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008
10. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
11. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...A, Va., Nov. 9 CEL-SCI C... Dr. Kenneth S. Rosenthal, Professor of Immunology...s College of Medicine and Pharmacy, reported on wo...he Cleveland Clinic and CEL-SCI on CEL-SCI,s LEAPS...e 7th GTCbio Vaccine: "All Things Considered" Conf...
(Date:11/8/2009)...UNTAIN VIEW, Calif. Nov. 5, 2009 Complete Genomi...pany, today announced publication of a report in t...A sequencing platform, including analysis of seque...nsumables cost for these three genomes sequenced o...nged from $8,005 for 87x coverage to $1,726 for 45...
(Date:11/6/2009)...Y, Mass., Nov. 6 Myriant Technolog...eloper and manufacturer of renewable bio-chemical...echnology provider Uhde GmbH, one of the world,s l...nnounced an alliance for the engineering, procurem... Succinic Acid plants based on renewable feedstock...
(Date:11/6/2009)...RD, Calif., Nov. 6 Intarcia Therap...its ITCA 650 (DUROS® continuous delivery of e...etes at the Ninth Annual Diabetes Technology Meeti...newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...e Via ITCA 650 Lowers Plasma Glucose, HbA1c and Re...
Breaking Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasd...07, the Company received notification from the NAS...ot in compliance with the $35 million,market value...sting on The,NASDAQ Capital Market set forth in NA... with Marketplace Rule 4310(c)(8)(C), the Company ...
... for Sept. 3, UPPSALA, Sweden and WILMINGTON, Mas...de Bruyne, M.D., Ph.D., will present the,benefits ... Reserve (FFR),in improving the outcomes of multiv... Cardiology (ESC) Congress 2007 in Vienna. The EBA...Medical Systems, will take place at,12:45 p.m. CES...
...erenium,Corporation (Nasdaq: VRNM ), a leading de...neer in the development of high-performance specia...President and Chief Executive,Officer of Verenium,...,Energy Conference. The presentation is scheduled ... 2007 and will take place at Le Parker Meridien in...
Other Biology Technology:Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq 2Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007 2Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 2Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 3
(Date:11/9/2009)...e University evolutionary biologists David Queller...h cooperation and low conflict between components,... its "organismality," whether that thing is an ani... the traits scientists use to describe an organism...same species, may not be necessary to achieve orga...
(Date:11/9/2009)... PALO ALTO, Calif., Nov. 9 Genenco...stainable Energy Award" from the American Institut...e® family of enzymes for cellulosic ethanol. ... committee, presented the award to Landon Steele, ...ellerase® Product Manager, and Aaron Kelley, ...
(Date:11/9/2009)...LADELPHIA, NOVEMBER 9, 2009 A nutritionist whose...getables to the federal Women, Infants and Childre...es Agnes Higgins Award for outstanding achievement...ail Harrison, Ph.D., MNS, , a professor in the Dep...sity of California, Los Angeles School of Public H...
Breaking Biology News(10 mins):What is the meaning of 'one'? 2What is the meaning of 'one'? 3Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 1Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 2Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillions Clinical Workstation Solution 53221 3Air Methods to Report Second Quarter Financial Results After Market Close on Thursday August 6 2009 53219 1Medicagos H1N1 pandemic vaccine candidate shows positive response in 100 25 of vaccinated animals after a single dose 13289 1Medicagos H1N1 pandemic vaccine candidate shows positive response in 100 25 of vaccinated animals after a single dose 13289 2Medicagos H1N1 pandemic vaccine candidate shows positive response in 100 25 of vaccinated animals after a single dose 13289 3
...altimore, MDStem cells are the body,s primal cells...ore specialized types of cells over many cycles of...he Carnegie Institution have identified a gene, na...eping a variety of stem cells in their undifferent... their potency has implications both for our knowl...
...EW YORK, Jan. 6, 2009 Scientists have discovered ...unrelated bacterial species, a finding that raises...g of toxins and other disease-aiding factors may b...oratory experiment, the scientists from NYU School..., a notorious bacterium that causes toxic shock sy...
...INCINNATI Mutation of a gene that helps proteins ...enter the nucleus puts some families at higher r...tizing encephalopathy (ANE). , This is the conclu...he American Journal of Human Genetics , and curre...rom Cincinnati Children,s Hospital Medical Center....
Other Biology News:'Scrawny' gene keeps stem cells healthy 2NYU scientists discover dangerous new method for bacterial toxin transfer 2NYU scientists discover dangerous new method for bacterial toxin transfer 3NYU scientists discover dangerous new method for bacterial toxin transfer 4Genetic mutation causes familial susceptibility for degenerative brain disease 2Genetic mutation causes familial susceptibility for degenerative brain disease 3
...um atoms at the 3, 3', 4, and 4' positions. It is ...uantification of Prostaglandin E2 (PGE2) by GC- or...cyclooxygenase products of arachidonic acid and on...Its activity influences inflammation, fertility an...
Agarose Gel Loading Dye Mixture 6X (with ficoll) from GenScript Corporation
Site-directed DNA Mutagenesis Service from Yorkshire Bioscience Ltd
Treponema Pallidum Total ELISA Kit, Single from Bio-Quant Inc.
Biology Products: